Banque Transatlantique Sa Pacific Biosciences Of California, Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 577 shares of PACB stock, worth $530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
577Holding current value
$530% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
227MCall Options Held
2.15MPut Options Held
967K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$33.6 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$21.7 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$21.5 Million4.62% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.9MShares$20.1 Million0.46% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$18.8 Million0.08% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $207M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...